Detection and discrimination of tachycardia in ICDs manufactured by St. Jude Medical;Erkennung und Klassifizierung von Tachykardien bei ICDs von St. Jude Medical

Herzschrittmachertherapie und Elektrophysiologie

Volumn 27, Issue 3, 2016, Pages 226-239

  Zdarek, Jan ^a   Israel, Carsten W ^b  

^a St Jude Medical   (Germany)

^b EVANGELISCHES KRANKENHAUS   (Germany)

Author keywords

Implantable cardioverter defibrillator; Sudden cardiac death; Tachyarrhythmia, ventricular; Tachycardia, supraventricular; Ventricular fibrillation

Indexed keywords

ALGORITHM; ARTICLE; ATRIAL FIBRILLATION; AUTOMATION; BIOMEDICAL TECHNOLOGY ASSESSMENT; DISEASE CLASSIFICATION; EQUIPMENT DESIGN; HEART ATRIUM FLUTTER; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MEDICAL DEVICE COMPLICATION; RISK REDUCTION; SENSITIVITY ANALYSIS; SINUS TACHYCARDIA; SUDDEN CARDIAC DEATH; SUPRAVENTRICULAR TACHYCARDIA; TACHYCARDIA; ARTIFACT; COMPUTER ASSISTED DIAGNOSIS; COMPUTER ASSISTED THERAPY; DEVICE FAILURE ANALYSIS; DEVICES; DISCRIMINANT ANALYSIS; ELECTROCARDIOGRAPHY; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL ERROR; PREVENTION AND CONTROL; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

ALGORITHMS; ARTIFACTS; DEFIBRILLATORS, IMPLANTABLE; DIAGNOSIS, COMPUTER-ASSISTED; DISCRIMINANT ANALYSIS; ELECTROCARDIOGRAPHY; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; EVIDENCE-BASED MEDICINE; HUMANS; MEDICAL ERRORS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TACHYCARDIA, VENTRICULAR; THERAPY, COMPUTER-ASSISTED; TREATMENT OUTCOME;

EID: 84986272533     PISSN: 09387412     EISSN: 14351544     Source Type: Journal    
DOI: 10.1007/s00399-016-0455-1     Document Type: Article

References (13)

1. Bailin SJ, Niebauer M, Tomassoni G et al (2003) Clinical investigation of a new dual-chamber implantable cardioverter defibrillator with improved rhythm discrimination capabilities. J Cardiovasc Electrophysiol 14:144–149
2. Bedair R, Babu-Narayan SV, Dimopoulos K et al (2014) Acceptance and psychological impact of implantable defibrillators amongst adults with congenital heart disease. Int J Cardiol 181:218–224. doi:10.1016/j.ijcard.2014.12.028
3. Daubert JP, Zareba W, Cannom DS et al (2008) Inappropriate Implantable Cardioverter-Defibrillator Shocks in MADIT II. J Am Coll Cardiol 51:1357–1365. doi:10.1016/j.jacc.2007.09.073
4. Dickstein K, Vardas PE, Auricchio A et al (2010) 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Europace 12:1526–1536. doi:10.1093/europace/euq392
5. Guedon-Moreau L, Chevalier P, Marquie C et al (2010) Contributions of remote monitoring to the follow-up of implantable cardioverter-defibrillator leads under advisory. Eur Heart J 31:2246–2252. doi:10.1093/eurheartj/ehq203
6. Poole JE, Johnson GW, Hellkamp AS et al (2008) Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 359:1009–1017
7. Powell BD, Saxon LA, Boehmer JP et al (2013) Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study. J Am Coll Cardiol 62:1674–1679. doi:10.1016/j.jacc.2013.04.083
8. Saxon LA, Hayes DL, Gilliam FR et al (2010) Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study. Circulation 122:2359–2367. doi:10.1161/CIRCULATIONAHA.110.960633
9. Schron EB, Exner DV, Yao Q et al (2002) Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 105:589–594
10. Schwab JO, Bonnemeier H, Kleemann T et al (2015) Reduction of inappropriate ICD therapies in patients with primary prevention of sudden cardiac death: DECREASE study. Clin Res Cardiol Off J Ger Card Soc 104:1021–1032. doi:10.1007/s00392-015-0870-z
11. Theuns DAMJ, Rivero-Ayerza M, Goedhart DM et al (2008) Morphology discrimination in implantable cardioverter-defibrillators: consistency of template match percentage during atrial tachyarrhythmias at different heart rates. Europace 10:1060–1066. doi:10.1093/europace/eun194
12. Tracy CM, Epstein AE, Darbar D et al (2012) 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 60:1297–1313. doi:10.1016/j.jacc.2012.07.009
13. Tzeis S, Andrikopoulos G, Kolb C, Vardas PE (2008) Tools and strategies for the reduction of inappropriate implantable cardioverter defibrillator shocks. Europace 10:1256–1265. doi:10.1093/europace/eun205